Supported by

Accelerating new and better interventions for depressed mood

Commissioned by Wellcome, the Mental Health Catalyst is a structured, end-to-end programme designed to:

Improve understanding of the pathways and mechanisms contributing to clinically significant depressed mood
Identify and prioritise interventions with the potential to meaningfully improve outcomes
Accelerate the development, evaluation and implementation of promising interventions
Address systemic barriers limiting the scaling and sustained adoption of effective interventions

Clinically significant depressed mood remains one of the most pressing challenges in global mental health. Despite major advances in scientific understanding, progress in translating research into interventions that deliver sustained real-world impact has remained uneven and slow. The Mental Health Catalyst has been established to help accelerate the development and adoption of more effective, scalable and sustainable interventions that can meaningfully improve outcomes.

Generation Mental Health

Generation Mental Health is a global movement working to transform mental health systems so that they better reflect the needs and priorities of young people. Through its international network, the organisation mobilises lived experience perspectives, supports youth leadership and promotes collaboration across research, policy and practice communities. Within the Mental Health Catalyst, Generation Mental Health supports the design and coordination of lived experience expert engagement, ensuring that the perspectives of people affected by depressed mood inform programme design, activities and outputs.

Cochrane

Cochrane is an international network dedicated to producing high-quality, trusted evidence to inform health decisionmaking. Its systematic reviews are widely regarded as the global standard for rigorous evidence synthesis in healthcare. Within the Mental Health Catalyst, the Cochrane Evidence Synthesis Unit Germany / UK leads the systematic evidence synthesis and pathway mapping work, applying transparent and reproducible methods to integrate evidence across biological, psychological and socio-ecological domains. This work provides the foundation for the collaborative identification of strategic intervention points and informs the downstream innovation and prioritisation activities.

YPMH

The William Templeton Foundation for Young People’s Mental Health is a charitable foundation dedicated to reducing the prevalence and impact of mental health conditions among young people. It focuses on accelerating the translation of research into practical interventions that can prevent and reduce mental ill health across the life course. Working with researchers, innovators, practitioners, educational institutions, policymakers and young people themselves, YPMH supports initiatives that strengthen understanding of mental health conditions and accelerate the development and implementation of effective, scalable solutions capable of delivering real-world impact.

University of Cambridge

Founded in 1209, the University of Cambridge is one of the world’s leading universities, whose mission is to contribute to society through the pursuit of education, learning and research at the highest international levels. Cambridge has a long tradition of bringing together expertise across disciplines to address complex scientific and societal challenges. Its research spans the biological, psychological, clinical and social sciences, with major strengths in fields relevant to understanding and improving mental health. The Mental Health Catalyst is led by the University of Cambridge’s Institute for Manufacturing through its knowledge transfer company, IfM Engage. The programme draws on IfM Engage’s expertise in developing structured approaches to complex innovation challenges and translating knowledge into practical action, alongside the complementary expertise of the Catalyst’s collaborators and wider community of stakeholders.

Mental Health Innovation Network

The Mental Health Innovation Network (MHIN) is a global platform for sharing knowledge and experience on mental health innovation and implementation. Hosted by the London School of Hygiene & Tropical Medicine, MHIN connects researchers, practitioners, policymakers, funders, persons with lived experience, advocates, non-governmental organizations, civil society organisations, and other groups working to improve mental health services worldwide. Within the Mental Health Catalyst, MHIN engages stakeholders across Africa, Asia and Latin America, ensuring that diverse perspectives and priorities inform the Catalyst’s work and supporting dissemination of its outputs across the global mental health community.

Institute for Manufacturing Engage

IfM Engage is an embedded knowledge transfer company within the Institute for Manufacturing, University of Cambridge. Working with governments, international organisations, industry and research institutions worldwide, IfM Engage applies structured methods developed through IfM research to address complex innovation and systems challenges. These methods include roadmapping, ecosystem mapping, and strategic innovation methods that enable organisations to translate insight into coordinated action. Within the Mental Health Catalyst, IfM Engage leads programme design and delivery, facilitating collaboration and applying the structured approaches that underpin the programme. IfM Engage’s profits are reinvested into the University to support future research at the IfM.

IfM

The Institute for Manufacturing (IfM) is part of the University of Cambridge’s Department of Engineering, bringing together a dynamic body of researchers, educators, practitioners, professionals, and technical experts contributing to worldleading research and education. With a focus on manufacturing industries, the IfM creates, develops and deploys new insights into technology, management and policy. Its work in healthcare and life sciences spans innovation management, strategic and technology roadmapping, pharmaceutical supply networks, digitalisation, photonics and advanced fluidics.

The case for change:  why new approaches are needed

The central challenge is not a lack of research, but the failure to translate research into effective, user-acceptable interventions that can be delivered and sustained at scale.

Progress is often constrained by fragmented knowledge, weak prioritisation, poor alignment between innovation and delivery systems, and barriers within policy, infrastructure and implementation.

Addressing these challenges requires coordinated approaches that integrate scientific understanding, structured innovation and real-world implementation to accelerate meaningful and sustained improvements in outcomes.

We urgently need more effective, faster-acting and long-lasting ways to intervene early in depressed mood.

Too often, promising research does not translate into interventions that reach people at scale. Initiatives like the Mental Health Catalyst are critical because they bring together expertise across research, innovation and implementation to identify and accelerate the most promising opportunities for impact."

Max Ahmed

Head of Mental Health Innovation, Wellcome

A structured approach to accelerating impact

Understand : Innovate : Implement

Developed through more than seven years of collaboration between the University of Cambridge’s Institute for Manufacturing (IfM), IfM Engage and The William Templeton Foundation for Young People’s Mental Health (YPMH), the Understand : Innovate : Implement methodology integrates evidence synthesis, structured innovation, systems thinking and implementation-focused change management.

Understand

Understand focuses on clarifying the pathways, factors and mechanisms contributing to depressed mood, helping identify evidence-informed opportunities for intervention

Innovate

Innovate focuses on identifying and prioritising promising intervention opportunities with the potential to meaningfully improve outcomes

Implement

Implement focuses on enabling effective interventions to be adopted, scaled and sustained through implementation design, behaviour change and coordinated action across health systems and wider societal ecosystems.

Catalyst 1.0 and beyond

Identify and mobilise

The Mental Health Catalyst aims to make clinically depressed mood a short-lasting condition that does not affect lives in the longer term through the development and adoption of more effective, faster-acting and longer-lasting interventions that can be sustainably delivered at scale.

Catalyst 1.0 is a four-year programme focused on identifying prioritised, evidence-informed intervention opportunities for clinically significant depressed mood, including depressive disorders and depressed mood occurring within anxiety disorders and bipolar disorder. The programme is principally treatment-focused, aiming to identify interventions that are acceptable, faster-acting, scalable and capable of reducing relapse and improving longer-term outcomes.

At the same time, the programme examines the biological, psychological and socio-ecological pathways contributing to depressed mood across the life course, helping identify opportunities relevant to prevention, early detection, diagnosis and stratified approaches to management and treatment.

Looking ahead, Catalyst 2.0 aims to build global capability for translating mental health research into scalable real-world impact.

How can you contribute?

The Mental Health Catalyst is designed as a highly collaborative initiative.

Partnership is embedded throughout the programme, enabling deeper insight, co-development of solutions and coordinated approaches for translating research into real-world impact.

The Catalyst brings together researchers, clinicians, health strategists, innovators, policymakers, funders and people with lived experience to help accelerate the development and adoption of interventions that can improve outcomes for people experiencing mental ill health.

We warmly invite individuals and organisations to contribute in several ways:

Contributing expertise through Expert Advisory Panels and consultations
Participating in stakeholder workshops and surveys
Supporting the development and validation of prioritised interventions emerging from Catalyst 1.0
Collaborating in the next phase of the programme, Catalyst 2.0

Your expertise, experience and partnership can help shape evidence-informed approaches that deliver meaningful improvements in mental health outcomes.

To learn more or explore opportunities to collaborate, please contact the Catalyst team at mhc-enquiries@eng.cam.ac.uk.

Catalyst Updates

May 25, 2026

Projects to deliver Mental Health Catalyst 1.0

Mental Health Catalyst 1.0 is a four-year programme commissioned by Wellcome to accelerate the development, translation and uptake of new and better interventions for conditions associated with depressed mood.

May 25, 2026

Evidence synthesis and pathway mapping: building the foundation for new and better interventions

Clinically significant depressed mood remains one of the most pressing challenges in global mental health. Although scientific understanding has advanced substantially, progress in translating research into interventions that deliver sustained impact at scale has been uneven and slow.

March 24, 2026

Announcement, 24 March 2026

The University of Cambridge has launched a major new initiative designed to accelerate the pace of innovation in interventions for conditions associated with clinically significant depressed mood.

Get involved